Spelling suggestions: "subject:"amongmedical"" "subject:"andmedical""
151 |
Multimerin, a Platelet and Endothelial Cell ProteinHayward, Pauline Mary Catherine 05 1900 (has links)
<p>p-155 is a soluble platelet protein, with a reduced subunit mobility of 155 kDa, that was first identified using a monoclonal antibody raised against platelets. This thesis describes the identification and characterization of p-155, including its structure, biosynthesis, cells of origin, and cDNA sequence. Studies of the native p-155 protein indicated that it is comprised of variably sized, disulfide linked multimers of p-155 subunits, ranging in size from a 400 kDa trimer to large multimers, many millions of daltons in size. Based on its massive, multimeric structure, the native p-155 protein was designated as multimerin. Comparisons with other multimeric proteins found in platelets indicated that multimerin is a novel protein and also one of the largest proteins stored in platelets. In addition to platelets, multimerin was also found in endothelial cells. Biosynthetic metabolic labeling studies indicated that multimerin is synthesized by Dami cells (a megakaryocytic cell line), and by endothelial cells. Multimerin is a highly glycosylated protein with complex, N-linked carbohydrate accounting for 1/3 of its molecular mass. Cleveland mapping studies were used to investigate the relationship between the different sized multimerin subunits found in platelets and Dami cells. These studies demonstrated peptide homology, indicating that p-155 and p-170 (a larger but less abundant multimerin subunit found in platelets) originate from p-196, the multimerin precursor protein identified in metabolic labeling studies.</p> <p>Multimerin antibodies were used to screen expression human endothelial cell libraries for multimerin cDNA clones and the most 5' cDNA clone was used to rescreen the library for complete 5' sequence. The complete cDNA sequence for multimerin was then determined. The multimerin cDNA sequence encodes a hydrophilic protein of 1228 amino acids with RGDS, EGF-like, partial EGF-like, and putative coiled-coil domains. In addition, the C-terminal region of multimerin resembles the globular head domain of complement Clq and collagens type VIII and X. These studies establish multimerin as a unique, multimeric platelet and endothelial cell protein. The massive size, GDS motif, and repeating structure of multimerin suggest a possible role for this protein in adhesion.</p> / Doctor of Philosophy (PhD)
|
152 |
Regulation of Human Antithrombin Gene Expression. (1) Mapping of a Deletion Including in Part the Promoter Region. (2) Characterization of Cis-Acting Elements and Transcription Factors Binding to This RegionFernandez-Rachubinski, Francoise 03 1900 (has links)
<p>This thesis addresses regulatory aspects of the constitutive expression of human antithrombin, a serine-protease inhibitor involved in coagulation and thrombosis. An introductory part describes a 5'partial deletion, 480 nt upstream of the third exon of an antithrombin allele, in a kindred with thrombosis and hereditary deficiency in antithrombin. The lack of expression of the abnormal allele prompted the further characterization of elements regulating transcription in the 5' region of the normal antithrombin gene. Two cis-acting elements were found, both able to promote transcription in HepG2 and Cos I cells. The first promoter, at -150/+68 nt, encompassed the presumed transcriptional start site. The second element, in reverse orientation in regard to the first, was located at +895/+391 nt in the first intervening sequence. Following footprint analysis, it was shown that the 5'upstream promoter interacted with trans-acting factors at -92/-65 nt, -11/+37 nt and -124/-10 nt, in nuclear extracts from hepatic or non-hepatic origin. Several transcription-factors were subsequently identified, which interacted with these three elements either through direct binding or heterodimerization; they were the liver-enriched factors HNF4 and C/EBPα as well as the ubiquitous nuclear hormone receptors COUP-TF1, RXRα, PPARα and TRα. Furthermore, in vivo expression in HepG2, HeLa and BSC40 cells, of HNF4, C/EBPα and RXRα increased the efficiency of the 5'upstream promoter, while expression of COUP-TFl, TRα, HNF3α or β repressed the efficiency of the latter promoter and the activating effects of HNF4. In addition, activation by HNF4 was synergized by co-expression of RXRα in BSC40 and HeLa cells. These results suggest that the interplay of liver-enriched and ubiquitous factors modulates the constitutive expression of the antithrombin gene.</p> / Doctor of Philosophy (PhD)
|
153 |
Cognitive processes in emotion recognition: A pet study of men, women and adults with autismHall, Brian Charles Geoffrey January 2001 (has links)
<p>We were interested in localizing the regionally specific brain responses which underlie the emotion processing strategies of men, women and a clinical population of individuals with emotion processing deficits: autism. In two studies we identified the brain regions involved in the recognition of emotion by measuring changes in regional cerebral blood flow (rCBF) using positron tomography. Study I asked adult men and women to perform face detection, identity matching and emotion matching tasks and compared the distribution of rCBF produced by each task. The recognition of facial emotion by males was associated with activation of the right inferior frontal cortex, whereas in females, activation of the frontal cortices bilaterally, and the right middle temporal and right inferior occipital gyri was identified. Between-group comparisons of the activations associated with facial emotion processing revealed that males showed greater right sided activation of medial frontal and superior occipital regions and less activation of the left inferior frontal gyrus, left fusiform gyrus and right amygdala than did women. Localization of function to these regions is consistent with other research results identifying greater distribution and less lateralization of cognitive functions in females than males. In our second study we presented cross-modal (auditory-visual) gender matching and emotion matching tasks to three groups of adults; men, women, and high functioning men with autism. Compared to the gender matching task, emotion matching was associated with activation of a left inferior frontal region in males, and the right superior temporal gyrus and right anterior cingulate gyrus in females. This pattern was similarly reflected in between-group comparisons, which identified significantly greater activations in a left inferior frontal region for males, and greater anterior cingulate and fusiform activations for females. These results identify sex differences in cross-modal emotion processing. Localization to these regions suggests that females placed greater relative processing emphasis on the auditory-prosodic and motivational qualities of the current experience, whereas males relied more on processes engaged in the construction of an integrated emotional experience and the regulation of responses. Cross-modal emotion matching by adults with autism was associated with activation of Broca's region, and bilateral anterior temporal poles. Between-group comparisons identified significantly greater activation of the right anterior temporal pole and anterior cingulate by the adults with autism, as compared to controls. These findings suggest that the adults with autism placed greater emphasis on processes involved in accessing perceptual knowledge to guide the categorization of emotional stimuli, verbal problem solving, directing attention toward cross-modal information sources and/or assessing the motivational content of stimuli.</p> / Doctor of Philosophy (PhD)
|
154 |
Fibroblast Heterogeneity and Pulmonary FibrosisTorry, Diane J. 11 1900 (has links)
<p>Idiopathic pulmonary fibrosis is a chronic inflammatory disease of the lung characterized by pathologic alterations with fibroblast proliferation and disordered deposition of extracellular matrix resulting in impairment of gas exchange often leading to respiratory failure. In the pulmonary interstitium, the fibroblast and the extracellular matrix products they produce, play a pivotal role in maintaining the structural and functional integrity of the lung.</p> <p>In the study of lung fibrosis and other fibrosing diseases much attention has been directed at events which alter fibroblast activities. In this construct however, the lung fibroblast is viewed merely as a homogeneous target cell altering its behaviour as a result of immune and inflammatory events. Importantly, it has become apparent over the years that (1) fibroblasts are themselves effector cells capable of releasing a variety of growth factors and mediators and (2) that fibroblasts comprise a heterogeneous population, both within and between tissues. Therefore, an alternative, but not a mutually exclusive hypothesis considers the heterogeneous nature of the fibroblast population and the potential contribution of various subpopulations to disease expression.</p> <p>Our first report that fibroblasts derived from chronically activated and inflamed human lung tissue behaved differently than normal fibroblasts suggested that fibroblast populations present in fibrotic lung tissue exhibited accelerated growth rates. In order to further examine the growth characteristics of fibrotic lung fibroblasts, a soft agarose culture system was established in which we examined the ability of lung fibroblast primary lines to form colonies under anchorage-independent growth conditions, possibly equating to aggressive or "transformed" behaviour. Fibroblasts derived from the Iungs of patients with idiopathic pulmonary fibrosis exhibited anchorage-independent growth in soft agarose culture whereas fibroblast lines derived from normal adult tissue did not. These colonies were fibroblast-like according to morphology and immunohistochemical stain characteristics, and the ability to grow under semi-solid growth conditions was maintained by the fibrotic derived cells even after selection and expansion of single colonies. Interestingly, fibroblast cell lines derived from neonatal lung tissue also exhibited the ability to grow as colonies under soft agarose growth conditions suggesting newly differentiated fibroblast populations may be prevalent in fibrotic lung tissue.</p> <p>The effect of various growth and differentiating factors on the modulation of the anchorage-independent colony formation phenotype was examined in vitro. Treatment with various growth factors, including PDGF, FGF, EGF, TGFβ and corticosteroid were able to modify the colony forming abilities of fibrotic and neonatal fibroblast lines. Importantly, none of the above treatments was able to induce fibroblasts derived from normal adult lung tissue to form colonies. The ability of IPF fibroblast lines and neonatal lung fibroblast lines to form colonies under soft agarose growth conditions was inhibited by treatment with retinoids, known differentiating agents, implying the modulation/differentiation of a particular fibroblast phenotype toward a more mature phenotype; one incapable of anchorage-independent growth.</p> <p>Since the ability to form colonies under soft agarose growth conditions by fibrotic fibroblasts appeared to be a stable and disease specific phenotype and since in vitro we were able to successfully modulate this behaviour with retinoids, we examined the effect of orally administered retinoic acid on the modulation of the fibrotic lung response in a rat model of bleomycin induced pulmonary fibrosis. In this study, we report that the in vivo administration of all-trans retinoic acid significantly decreased the number of fibrotic lesions and dramatically altered the pattern of collagen deposition in the bleomycin treated lung.</p> <p>These studies have confirmed and extended our earlier hypothesis concerning the contribution of fibroblast heterogeneity to the pathogenesis of pulmonary fibrosis and suggests avenues of intervention that may lead to alteration of the fibrotic tissue and return to normal lung function.</p> / Doctor of Philosophy (PhD)
|
155 |
Anorexia and inflammation: Food intake studies in a rat model of intestinal inflammation.McHugh, James Kevin January 1994 (has links)
<p>This research examines the hypothesis that in rats inflammation of the gastrointestinal tract results in a specific decrease of food intake. A model for examining gastrointestinal inflammation, the trinitrobenzene sulphonic acid model, and its effects on feeding is developed and investigated in the rat. The TNB model results in a predictable and reproducible colonic inflammation that is accompanied by a rapid but transient decrease in food intake. Experiments are presented which: i)investigate if the anorexia is due to nonspecific malaise. ii)investigate, by meal pattern analysis, the profile of food intake displayed by TNB treated animals iii)investigate specifically, which mediators released from the sight of inflammation could be an anorexigenic signal to the central nervous system.</p> <p>To demonstrate that the anorexia is not due to malaise we have shown that the anorexia: is not specific to the TNB model, is accompanied by no decrease in water intake and develops even when animals are maintained on highly palatable or low residue liquid diets. More importantly animals specifically decrease meal size not meal frequency. Decreased meal size with maintenance of meal frequency is consistent with the generation of abnormal satiety signals and not a "general malaise." These findings show that rats are capable of performing the behaviours necessary for food intake, and do not show specific conditioned taste aversions.</p> <p>The hypothesis that the generation of abnormal gastric and/or post-gastric satiety signal is responsible for TNB induced anorexia was also investigated. I demonstrated removal of both gastric and post-gastric satiety signals in a sham feeding preparation resulted in normal intake even in otherwise anorexic animals. I also show that animals with TNB induced colonic inflammation, present with a decreased rate of gastric emptying. These data raise the possibility that abnormal satiety signals, generated as a result of decreased gastric emptying result in decreased meal size and an overall anorexia.</p> <p>Finally, by specifically inhibiting synthesis of leukotrienes and prostaglandins respectively, or by using an interleukin-1 receptor antagonist (rhIL-1ra), I examined the role of these inflammatory mediators in the anorexia seen in the TNB model of colitis in the rat. I demonstrate that inhibition of prostaglandin synthesis and blockage of interleukin-1 receptors particularly in the brain, result in a significant attenuation of the anorexia. I conclude that the full expression of the anorexia observed in TNB treated animals is dependant on the production of prostaglandins and occupation of centrally located interleukin-1 receptors. Thus, here I specifically describe a model suitable for the investigation of the mechanisms of gastrointestinal inflammation induced anorexia and generally a model that may be used to examine how peripherally generated signals can alter behaviour by communication with the central nervous system.</p> / Doctor of Philosophy (Medical Science)
|
156 |
Modulation of ozone-induced airway hyperresponsiveness by cyclooxygenase and nitric oxide synthaseWatson, (Ted) Edward G. 10 1900 (has links)
<p>A large number of studies have identified that bronchoconstricting agents have increased potency and effect following inhaled ozone, but the contribution of bronchodilatory mediators to attenuation of the airway hyperresponsiveness observed following inhaled ozone remains unclear. The purpose of this investigation was to identify the contribution of nitric oxide synthase (NOS) and cyclooxygenase (COX) to the regulation of ozone-induced airway hyperresponsiveness. These mediators are derived largely from the airway epithelium and ozone exposure is likely, through epithelial damage, to alter the effect of NOS and COX in the airway. Using an ozone exposed guinea pig model of airway hyperresponsiveness, the in vivo responses to inhaled histamine were compared to responses in sham treated animals. Administration of the NOS inhibitor L-NAME (5120 μg/mL) increased the histamine sensitivity after ozone treatment. The non-selective COX inhibitor indomethacin (10 mg/kg) also increased the histamine sensitivity after ozone treatment. The COX-2 selective inhibitor DFU (1 or 10 mg/kg) caused a 2-fold leftward shift after ozone exposure, similar to that observed with indomethacin. The thromboxane antagonist, SQ 29,548 (1 mg/kg i.p.) attenuated the histamine responsiveness in a time dependent manner. The combination of COX and NOS inhibition produced a histamine-induced airway hyperresponsiveness greater than that observed with either NOS or COX inhibition alone. Pre-administration of dexamethasone inhibited the ozone-induced histamine hyperresponsiveness at all time points. Biochemical measurements of NOS activity identified an increase in NOS enzyme activity following ozone. Bronchoalveolar lavage revealed an inflammatory cell profile that did not correlate to the in vivo airway hyperresponsiveness. In vitro tissue bath experiments identified the presence and biological activity of NOS in the guinea pig trachea. Liquid chromatographic detection of nitric oxide metabolites and Western blot detection of COX-2 and NOS isoforms did not provide reliable data. This thesis demonstrates that histamine airway responsiveness following ozone changes rapidly and that both NOS and COX are upregulated a few hours after ozone exposure and, through functional antagonism, modulate ozone-induced histamine airway hyperresponsiveness.</p> / Doctor of Philosophy (PhD)
|
157 |
The contribution of mitochondrial function to the energetics of cell cycle progressionSweet, Susan 12 1900 (has links)
<p>Mitochondria play a critical role in the provision of energy to individual cells through the synthesis of ATP. The relationship between mitochondrial energy production and cell cycle progression has been explored in this work with the intention of defining the fuel requirements of the cell cycle engine. Because mitochondrial physiology and cell division proved to be intimately linked, we also examined the feasibility of disrupting mitochondrial properties in order to alter cell cycle dynamics. We show that the rate of utilization of mitochondrially-derived ATP fluctuates throughout the cell cycle and that stages where ATP levels are lowest correspond to stages most sensitive to pharmacologic inhibition of mitochondrial function. These particular transition points comprise theoretical "energetic checkpoints" of cell cycle progression. It is here that the biochemical events that are sensitive to changes in the cellular energy status will determine whether the cell continues through its cycle or pauses until a favourable energetic balance is restored. The increase in the number of cells in the G1 component of the cell cycle that results from antagonizing mitochondrial function is accompanied by an augmented proportion of persistently active Retinoblastoma protein (Rbp). Failure to inactivate this tumour suppressor protein, whose role it is to brake cell cycle progression in response to suboptimal conditions, does not result from an upregulation of the "classical" G1 inhibitory proteins but rather does so secondary to a decrease in the availability of a critical G1 cyclin. This sensitive regulatory protein, cyclin D, is essential for the activation of kinases responsible for the initial phosphorylation of Rbp, which renders it inactive and allows passage out of the G1 component of the cell cycle. This is the first work to report cell cycle-specific periods of increased ATP utilization which correlate with checkpoints through which a cell will not pass if its energetic balance is sufficiently disrupted. We also demonstrate that changes in mitochondrial function elicit changes in the core proteins of the cell cycle machinery suggesting some intracellular link between the energy balance within the cell and the proteins responsible for cell cycle progression. Finally this report confirms previous suggestions that mitochondria represent viable targets for altering the division characteristics of a cell population, particularly in the context of the altered mitochondrial phenotype of many tumour cells.</p> / Doctor of Philosophy (PhD)
|
158 |
A structure-function relationship study involving the first epidermal growth factor-like domain of human coagulation factor VIILeonard, John Normand Blair 06 1900 (has links)
<p>The interaction of circulating coagulation factor VII with cell surface associated tissue factor (TF) is critical for the initiation of blood coagulation, and appears to play a significant role in several other biological processes. Thus, an understanding of the mechanism of this interaction should provide valuable insight into the development of these important processes. The first epidermal growth factor-like domain (EGF-1) of factor VII is the principle contact site with TF and possesses the structural elements characteristic of the ubiquitous EGF-like motif. The aim of this thesis was to investigate the relationship between the conformational structure of the EGF-1 domain in factor VII and its function in the initiator complex. Recombinant generation and analysis of a naturally occurring factor VII EGF-1 mutant (N57D) indicated a protein deficient in its cellular secretion, as well as possessing compromised procoagulant activity and TF binding capability. Using structural investigative techniques, this mutation was found to compromise the appropriate conformation of the EGF-1 domain via the loss of a previously undescribed, structurally-important intermolecular hydrogen bond, highlighting the delicate balance between conformation and function in this domain. Once developed, these structural investigative techniques allowed further investigation, indicating the EGF-1 domain adopted a conformation specific to the "active state" of factor VIIa and requiring the presence of calcium and the adjacent Gla domain. Once activated, occupation of the active site of factor VIIa with substrate-like inhibitors resulted in further conformational changes to the EGF-1 domain, indicating the presence of a novel active site occupant-specific allosteric linkage between the EGF-1 domain and the active site. This allosteric link also appeared to affect the functional processes of TF binding and enzymatic activity of the factor VIIa molecule. Overall, this study has contributed new knowledge on the relation of structural elements of the factor VII EGF-1 domain to the important factor VIIa functional processes of TF binding and enzymatic activity. As well, the study indicates a novel role for the EGF-1 domain in the unique co-factor mediated specificity observed for factor VIIa.</p> / Doctor of Philosophy (PhD)
|
159 |
The immunomodulation of the enteric nervous system: The effect of cytokines on neurotransmitter release and contentHurst, Maria Suzanne 02 1900 (has links)
<p>Inflammatory conditions of the gut, such as ulcerative colitis and Crohn's disease are associated with an alteration in intestinal motility. The mechanisms underlying altered motor function is unknown, but may be the result of alteration in smooth muscle and/or enteric nerve function. Recent studies using Trichinella spiralis (T.spiralis) infection of rats, as model of intestinal inflammation, have shown that the accompanying inflammatory response in these animals is associated with an altered enteric nerve function. These changes included a suppression of noradrenaline and acetylcholine release and an increased substance P content within the neuromuscular layer of the inflamed jejunum. Furthermore, there was an expression inflammatory cytokines within the mucosa and the deeper muscular layers of the jejunum within 12 hrs from the onset of T.spiralis infection. This elevation in cytokine expression occurred prior to the changes in myenteric neurotransmitters. It is therefore possible that inflammatory cytokines within neuromuscular layer cause a change in neurotransmitter release and content, and thus contribute to the altered gut motility observed in the nematode-infected rats.</p> <p>Addition of exogenous IL-1β or TNFα to isolated longitudinal musclemyenteric plexus (LM-MP) preparations caused a suppression of stimulated noradrenaline release, which was tiem and concentration dependent. This suppressive action was biphasic in manner, displayign an early protein synthesis independent effect and a delayed protein synthesis dependent effect. Furthermore, the delayed suppressive action of these cytokines on noradrenaline release were dependent on prostanoid synthesis. On examination of a putative direct interaction between these cytokines and adrenergic nerves using a nerve varicosity preparations, only IL-1β was found to suppress the evoked noradrenaline release. This suppressive action by IL-1β was time- and concentration-dependent, and in part, mediated by prostanoids. Although incubation of TNFα alone with the varicosities was unable to induce a response, the presence of TNFα did potentiate IL-1β-induced suppression of noradrenaline release. The conclusions drawn from this study are that TNFα causes a suppression of noradrenaline release from myenteric nerves which is evident only in a multicellular preparation and ilkely involves intermediary cells and their products including prostaglandins and/or thromboxanes. This contrasts with IL-1β, which in addition to an indirect effect, also suppressed noradrenaline release by directly interacting with adrenergic nerve terminals.</p> <p>IL-1β also caused an increase in substance P content within the myenteric plexus. The increase in this neuropeptide was time and concentration dependent, and could be depleted by scorpion venom. Immunohistochemical studies indicated that substance P was only found present within myenteric nerves. The IL-1β-induced increase in substance P was considered to be due to increased synthesis, since cycloheximide prevented the cytokine-stimulated increase substance P content induced by IL-1β. Moreover, the increase in substance P content was mediated by prostanoid synthesis, but not nerve growth factor. The conclusion drawn from these experiments is that IL-1β stimulates the synthesis of substance P within intrinsic nerves of the myenteric plexus.</p> <p>A putative role of endogenous IL-1 in the alteration of neurotransmitters in the T.spiralis model of intestinal inflammation was examined using a selective IL-1 receptor antagonist (IL-1ra). Treatment of the animals with IL-1ra prior to T.spiralis infection attenuated the suppressed noradrenaline release and increased substance P content observed in the inflamed LM-MP preparations. Therefore the results fro these experiments and those preformed using exogenous IL-1β and TNFα support and notion that inflammatory cytokines alters myenteric neurotransmitters, resulting in a disruption of enteric nerve function and thereby contributing to alterations n intestinal motility.</p> / Doctor of Philosophy (Medical Science)
|
160 |
Effect of 17-beta-estradiol and gender on substrate metabolism in humans during exerciseCarter, Lee Sherry 12 1900 (has links)
<p>Gender differences in substrate utilization have been observed with females having higher lipid and less carbohydrate oxidation during endurance exercise. This thesis consists of a series of three studies conducted with the overall objective of advancing our understanding of gender differences in substrate metabolism and the mechanism behind these differences. The first and second studies investigated the effect of endurance training on whole-body substrate, glucose and glycerol utilization muscle enzyme adaptations in males and females. Carbohydrate utilization was lower following endurance training when tested at the same absolute exercise intensity. Glucose rate of appearance (Ra) and metabolic clearance rate (MCR) were lower following training. Females had a lower glucose MCR later in exercise as compared to males. Regardless of training status, females had a higher glycerol Ra as compared to males suggesting a greater whole-body lipolysis. Gender differences in lipid utilization were not accompanied by gender differences in maximal enzyme activities, which increased following endurance training for both genders. The third study investigated the effect of 17-β-estradiol on whole-body substrate, glucose and glycerol utilization during endurance exercise in males. The administration of 17-β-estradiol resulted in a lower MCR during exercise as compared to placebo. 17-β-estradiol also resulted in a higher plasma glucose concentration during exercise, but had no effect on substrate oxidation, glycerol turnover or plasma glycerol and FFA concentrations at rest or during endurance exercise. It can be concluded that females have a higher whole-body lipolysis and oxidize a greater proportion of fat. The glucose kinetic data from the training study together with the data from the 17-β-estradiol study suggested that females used less hepatic glucose during endurance exercise. Although alterations in glucose kinetics were found following the administration of 17-β-estradiol to males further research is required to unravel the mechanism(s) behind the gender difference in substrate metabolism.</p> / Doctor of Philosophy (PhD)
|
Page generated in 0.0598 seconds